● Recruiting

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Condition: Idiopathic Gastroparesis · Diabetic Gastroparesis · Gastroparesis · Sponsor: Vanda Pharmaceuticals

PhasePhase 3

Planned participants100

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.

This description comes directly from the study's public registry record.

Talk to the study team

Vanda Pharmaceuticals · 202-734-3400 · clinicaltrials@vandapharma.com

Always discuss trial participation with your own doctor first.

Locations (3)

Vanda Investigational Site	Leuven, Belgium	Recruiting
Vanda Investigational Site	Liège, Belgium	Recruiting
Vanda Investigational Site	Leipzig, Germany	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06836557